Literature DB >> 7564877

Comparison of two pet radioligands for imaging extrastriatal dopamine transporters in human brain.

G J Wang1, N D Volkow, J S Fowler, Y S Ding, J Logan, S J Gatley, R R MacGregor, A P Wolf.   

Abstract

We compared the sensitivity of two dopamine transporter (DAT) ligands ([C-11]cocaine and [C-11]d-threo-methylphenidate) for measurement of extrastriatal DAT availability using positron emission tomography (PET) on separated groups of 10 age matched male volunteers (age range, 21-49 years). DAT availability was obtained using the ratio of the distribution volume in the region of interest to that in the cerebellum (Bmax'/Kd'+ 1). DAT availability measured with [C-11]d-threo-methylphenidate was highest in basal ganglia, followed by thalamus > temporal insula, cingulate > orbitofrontal, frontal and occipital cortices. A similar ranking order for DAT availability was obtained with [C-11]cocaine. Specific binding (Bmax'/Kd') of [C-11]cocaine in thalamus was 25-33% that of basal ganglia and [C-11]d-threo-methylphenidate in thalamus was 11-13% that of basal ganglia. The regional measures with [C-11]cocaine were significantly correlated with those of [C-11]d-threo-methylphenidate (p < or = 0.0001). These results document extrastriatal binding in human brain with two different DAT ligands.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7564877     DOI: 10.1016/0024-3205(95)02099-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  18 in total

1.  Fronto-striatal dysfunction during reward processing in unaffected siblings of schizophrenia patients.

Authors:  Max de Leeuw; René S Kahn; Matthijs Vink
Journal:  Schizophr Bull       Date:  2014-11-02       Impact factor: 9.306

2.  The primate thalamus is a key target for brain dopamine.

Authors:  Miguel Angel Sánchez-González; Miguel Angel García-Cabezas; Beatriz Rico; Carmen Cavada
Journal:  J Neurosci       Date:  2005-06-29       Impact factor: 6.167

3.  Progression of cellular adaptations in medial prefrontal and orbitofrontal cortex in response to repeated amphetamine.

Authors:  Houman Homayoun; Bita Moghaddam
Journal:  J Neurosci       Date:  2006-08-02       Impact factor: 6.167

4.  Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder.

Authors:  Hamid Mostafavi Abdolmaleky; Kuang-Hung Cheng; Stephen V Faraone; Marsha Wilcox; Stephen J Glatt; Fangming Gao; Cassandra L Smith; Rahim Shafa; Batol Aeali; Julie Carnevale; Hongjie Pan; Panagiotis Papageorgis; Jose F Ponte; Vadivelu Sivaraman; Ming T Tsuang; Sam Thiagalingam
Journal:  Hum Mol Genet       Date:  2006-09-19       Impact factor: 6.150

5.  D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD.

Authors:  Xueliang Fan; Ming Xu; Ellen J Hess
Journal:  Neurobiol Dis       Date:  2009-10-22       Impact factor: 5.996

6.  Auditory mismatch impairments are characterized by core neural dysfunctions in schizophrenia.

Authors:  Arnim Johannes Gaebler; Klaus Mathiak; Jan Willem Koten; Andrea Anna König; Yury Koush; David Weyer; Conny Depner; Simeon Matentzoglu; James Christopher Edgar; Klaus Willmes; Mikhail Zvyagintsev
Journal:  Brain       Date:  2015-03-04       Impact factor: 13.501

7.  The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome.

Authors:  Christopher J Earley; Hiroto Kuwabara; Dean F Wong; Charlene Gamaldo; Rachel Salas; James Brasic; Hayden T Ravert; Robert F Dannals; Richard P Allen
Journal:  Sleep       Date:  2011-03-01       Impact factor: 5.849

8.  Epistasis between the DAT 3' UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia.

Authors:  Diana P Prata; Andrea Mechelli; Cynthia H Y Fu; Marco Picchioni; Timothea Toulopoulou; Elvira Bramon; Muriel Walshe; Robin M Murray; David A Collier; Philip McGuire
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-28       Impact factor: 11.205

9.  Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects.

Authors:  Alexandre Eusebio; Jean-Philippe Azulay; Mathieu Ceccaldi; Nadine Girard; Olivier Mundler; Eric Guedj
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-14       Impact factor: 9.236

10.  Dexmethylphenidate hydrochloride in the treatment of attention deficit hyperactivity disorder.

Authors:  Feng Liu; Haruka Minami; Raul R Silva
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.